![3-{[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl}pyridine hydrochloride (1:1)](https://static.cymitquimica.com/cas-image/208376-3-5-23-dichlorophenyl-1h-tetrazol-1-yl-methyl-pyridine-hydrochloride-1-1.png)
CAS: 899507-36-9 - 3-{[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl}pyridine hydrochloride (1:1)
Formula:C13H10Cl3N5
InChI:InChI=1S/C13H9Cl2N5.ClH/c14-11-5-1-4-10(12(11)15)13-17-18-19-20(13)8-9-3-2-6-16-7-9;/h1-7H,8H2;1H
- Synonyms:
- 3-[[5-(2,3-Dichlorophenyl)-1H-tetra-zol-1-yl]methyl]pyridine hydrochloride
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | A 438079 REF: TM-T10207CAS: 899507-36-9 | 99.70% | 48.00 €~516.00 € | Wed 11 Dec 24 |
 | 3-[[5-(2,3-dichlorophenyl-1h-tetrazol-1-yl]methyl] REF: IN-DA006NFZCAS: 899507-36-9 | 98% | To inquire | Wed 11 Dec 24 |
 | A 438079 REF: 3D-ZKB50736CAS: 899507-36-9 | Min. 95% | To inquire | Wed 22 Jan 25 |
A 438079
CAS:899507-36-9
A 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).
Formula:
C13H9Cl2N5
Purity:
99.70%
Color and Shape:
Solid
Molecular weight:
306.15
Ref: TM-T10207
| 2mg | 48.00 € | ||
| 5mg | 71.00 € | ||
| 10mg | 95.00 € | ||
| 25mg | 176.00 € | ||
| 50mg | 291.00 € | ||
| 100mg | 516.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
![3-[[5-(2,3-dichlorophenyl-1h-tetrazol-1-yl]methyl]](https://static.cymitquimica.com/products/IN/thumb/DA006NFZ.jpg)
3-[[5-(2,3-dichlorophenyl-1h-tetrazol-1-yl]methyl]
CAS:899507-36-9
Formula:
C13H10Cl3N5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
342.6110
Ref: IN-DA006NFZ
| 10mg | 187.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
A 438079
CAS:899507-36-9
A 438079 is a research chemical known for its unique characteristics. It is an isothiocyanate …
Formula:
C13H10Cl3N5
Purity:
Min. 95%
Molecular weight:
342.61 g/mol
Ref: 3D-ZKB50736
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
